no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA
|
Bell, Christopher F. |
|
|
10 |
1 |
p. 261-274 |
article |
2 |
Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials
|
Tanaka, Yoshiya |
|
|
10 |
1 |
p. 161-185 |
article |
3 |
Causal Effect of Higher Glycated Hemoglobin (HbA1c) Levels on Knee Osteoarthritis Risk: A Mendelian Randomization Study
|
Chen, Lirong |
|
|
10 |
1 |
p. 239-247 |
article |
4 |
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry
|
Bergman, Martin J. |
|
|
10 |
1 |
p. 187-199 |
article |
5 |
Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis
|
Cohen, Stanley |
|
|
10 |
1 |
p. 1-6 |
article |
6 |
Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study
|
Combe, Bernard G. |
|
|
10 |
1 |
p. 71-72 |
article |
7 |
COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization
|
Azizi, Hossein |
|
|
10 |
1 |
p. 249-259 |
article |
8 |
Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO Cohort
|
Baydoun, Sara |
|
|
10 |
1 |
p. 225-238 |
article |
9 |
Discrepancy in Metabolic Syndrome between Psoriatic Arthritis and Rheumatoid Arthritis: a Direct Comparison of Two Cohorts in One Center
|
Li, Borui |
|
|
10 |
1 |
p. 135-148 |
article |
10 |
Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study
|
Combe, Bernard G. |
|
|
10 |
1 |
p. 53-70 |
article |
11 |
Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
|
McInnes, Iain B. |
|
|
10 |
1 |
p. 275-292 |
article |
12 |
Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
|
Wassenberg, Siegfried |
|
|
10 |
1 |
p. 117-133 |
article |
13 |
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases
|
Salinas, Claudia A. |
|
|
10 |
1 |
p. 201-223 |
article |
14 |
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis
|
Combe, Bernard |
|
|
10 |
1 |
p. 35-51 |
article |
15 |
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
|
Zhang, Ye |
|
|
10 |
1 |
p. 293-300 |
article |
16 |
Serum Calprotectin as a Promising Inflammatory Biomarker in Psoriatic Arthritis: a 1-Year Longitudinal Study
|
Li, Borui |
|
|
10 |
1 |
p. 149-160 |
article |
17 |
Systematic Literature Review and Meta-analysis of Venous Thromboembolism Events in Systemic Lupus Erythematosus
|
Bello, Natalia |
|
|
10 |
1 |
p. 7-34 |
article |
18 |
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis
|
Alten, Rieke |
|
|
10 |
1 |
p. 73-93 |
article |
19 |
Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses
|
Raymond, Kimberly |
|
|
10 |
1 |
p. 95-115 |
article |